Thank you, Jay. I would like to remind you that our typical contract period is from June 1 to May 31 of the following year. Net premiums written for the 3 months ended March 31, 2026, decreased to $555,000 from $595,000 for the quarter ended March 31, 2025. The decrease is due to a lower weighted average rate on reinsurance contracts in during the quarter ended March 31, 2026, when compared with the prior period. Our net investment income and other income for the 3 months ended March 31, 2026, decreased to $68,000 from $29,000 from prior comparable period. Along with net premiums, our total revenue amounted to $623,000 for the 3 months ended March 31, 2026, compared to $692,000 in the prior year comparable period. For the 3 months ended March 31, 2026, total expenses included policy acquisition costs and general admin expenses increased to $583,000 from $578,000 for the quarter ended March 31, 2025. The increase is primarily due to professional costs, investor relations and our work through subsidiary marketing. Net income for the quarter ended March 31, 2026, was $22,000 or 0 basic and diluted income per share compared to a net loss of $139,000 or $0.02 basic and diluted loss per share for the prior year quarter. The decrease in net loss is primarily due to a decreased allocation of underwriting income to token holders as the company itself is a major contributor in the 2025, 2026 treaty contract in place. Coupled with a decrease in unrealized loss on other investments during the quarter ended March 31, 2026, when compared with the prior period. As we have discussed before on our investor calls, we use various measures to analyze the growth and profitability of our business operations. For our reinsurance business, we measure underwriting profitability by examining our loss ratio, acquisition ratio, expense ratio and combined ratio. The loss ratio is a ratio of loss sales and loss adjustment expenses include the premiums earned and it measures the underwriting profitability of our reinsurance business. The loss ratio remained consistent at 0% for the 3 months ended March 31, 2026, when compared with the prior year comparative period. Our acquisition cost ratio, which measures operational efficiency, compares policy acquisition costs and net premiums earned. The acquisition cost ratio increased marginally to 11% for the quarter ended March 31, 2026, up from 10.9% for the prior year quarter. Our expense ratio, which measures operating performance compares policy acquisition costs and general and admin expenses with net premiums earned. For the 3-month period ended March 31, 2026, the expense ratio increased to $105,000 from $95,800 for the 3 months ended March 31, 2025. The increase is primarily due to increased professional costs, investor relations and our work through marketing and operations. Our combined ratio, which is used to measure underwriting performance, is the sum of the loss ratio and the expense ratio. For the 3 months ended March 31, 2026, the combined ratio increased to 105% from 95.8% for the 3 months ended March 31, 2025. The increase again is primarily due to increased professional costs related to Investor Relations and our W3 subsidiary marketing and operations. Now turning to the balance sheet. Cash and cash equivalents and restricted cash and cash equivalents increased by $1.21 million to $8.19 million, up from $6.98 million as of December 31, 2025. The increase is a net result of premium deposits made in the 3-month period ended March 31, 2026, as well as $1 million proceeds from a short-term loan that was secured. I'll now turn the call back over to Jay to wrap up before we take your questions. Jay?